Aprea Therapeutics, Inc. · NASDAQ:APRE
Aprea Therapeutics, Inc. shareholders
As of Jun 30, 2026, 27 institutions reported holding Aprea Therapeutics, Inc., 20.5% of its shares. Largest: AIGH Capital Management LLC, Nantahala Capital Management, LLC and Vestal Point Capital, LP. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Aprea Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| AIGH Capital Management LLC | 1.02M | 8.1% | no change | Aug 7, 2026 |
| Nantahala Capital Management, LLC | 412K | 3.3% | +206K | Aug 19, 2026 |
| Vestal Point Capital, LP | 350K | 2.8% | no change | Aug 14, 2026 |
| Sphera Funds Management LTD. | 270K | 2.1% | no change | Aug 14, 2026 |
| Renaissance Technologies | 106K | 0.84% | +80,700 | Aug 13, 2026 |
| Geode Capital | 74,869 | 0.59% | −44,262 | Aug 12, 2026 |
| Vanguard | 61,346 | 0.49% | +3,260 | Aug 13, 2026 |
| Citadel | 58,600 | 0.47% | new | Aug 14, 2026 |
| BNP Paribas | 45,211 | 0.36% | +5,394 | Aug 13, 2026 |
| Diadema Partners LP | 44,907 | 0.36% | new | Aug 14, 2026 |